For much of the past 15 years, emerging markets (EM) have been synonymous with disappointment. That perception is increasingly at odds with the structural reality of what the asset class has become.
During this period, an EM allocation has been an afterthought in global portfolio construction. Investors grew accustomed to performance gaps versus developed markets, recurring macro concerns and the perception of higher volatility.
The response from investors (perhaps understandably) was to reduce allocations progressively and concentrate capital in developed markets, particularly US equities. At Carmignac, we argue that investors should now reassess this decision, at a point when the structural foundations of the EM asset class are decisively shifting.
Emerging economies generate roughly 40% of global GDP and close to 70% of incremental global real growth, yet account for just 11% of global equity indices1.
Naomi Waistell and Xavier Hovasse, co-fund managers of Carmignac Portfolio Emergents, said: "This disconnect is not just a statistical anomaly. It is a mispricing of global economic reality. Investors remain anchored to an outdated narrative: EMs as fragile, commodity-dependent and policy-constrained. In reality, they have evolved into diversified, increasingly self-sufficient and innovation-driven economies. Failing to recognise this shift means underexposure to the very regions driving global growth."
The traditional case for EM exposure rested on leveraged participation in global growth cycles: high beta, driven by commodity prices and liquidity conditions. That paradigm has changed.
Today's EM universe is defined by technological leadership, industrial transformation and domestic demand expansion that is self-sustaining rather than dependent on developed market appetite.
"Asia, in particular, sits at the core of the global innovation ecosystem. Taiwan and Korea are indispensable to the semiconductor supply chain. China leads in robotics, EVs and industrial AI. India and Southeast Asia are driving digital adoption at scale," the Carmignac Portfolio Emergents fund managers said.
"Crucially, unlike in developed markets, AI in EM is not just a narrative. It is already embedded in the real economy, driving productivity gains, reducing costs and improving margins."
Asia, in particular, sits at the core of the global innovation ecosystem. Taiwan and Korea are indispensable to the semiconductor supply chain.

The improvement in corporate and sovereign quality across the emerging world is one of the least appreciated aspects of this shift. Fiscal positions across many EM economies are more disciplined than developed market counterparts. Central banks have rebuilt credibility: real interest rates are at 20-year highs, reflecting monetary orthodoxy and creating meaningful room to ease as inflation normalises.
At the company level, balance sheets are stronger, return on equity is improving and capital allocation is becoming more disciplined. Dividend yields are increasingly attractive and share buybacks are now at record levels in parts of Asia. Korean equity share cancellations leapt from 4.5 trillion KRW in 2023 to close to 18 trillion in 20252, a clear demonstration that governance reform is translating into shareholder-friendly behaviour.
Waistell and Hovasse said: "The traditional quality discount applied to emerging markets is becoming increasingly outdated. Yet valuations still reflect it."
The MSCI Emerging Markets index trades at around 11.9x forward 2026 earnings, approximately 43% below US equities and 32% below MSCI World. EM equities are forecast to deliver mid-to-high-teens EPS growth in 2026, materially above developed market consensus, yet trade below3 1x price-to-earnings-growth ratio against approximately 1.7x for developed markets4.
"This combination of higher growth at lower valuations is rare. And historically, it has been a powerful driver of long-term outperformance," the managers said.
The macro backdrop adds further support. A moderating US dollar reduces balance sheet stress and supports EM valuation multiples. Inflation has normalised across most of the asset class and high real interest rates offer attractive carry. Set against developed markets facing slowing growth, elevated debt and extreme equity market concentration, the relative attractiveness of EM is shifting in a way not yet reflected in most institutional allocations.
The traditional quality discount applied to emerging markets is becoming increasingly outdated. Yet valuations still reflect it.
![[Management Team] [Author] Hovasse Xavier](https://carmignac.imgix.net/uploads/NextImage/0001/18/%5BManagement-Team%5D-%5BAuthor%5D-Hovasse-Xavier-1.png?auto=format%2Ccompress&fit=fill&w=3840)
Global portfolios today carry significant hidden risks. Heavy exposure to US equities, combined with extreme concentration in a handful of technology mega-caps, creates valuation risk, concentration risk and regime risk, or the risk that the companies which have driven returns for a decade are displaced by a new generation of winners.
EMs offer something structurally different: diversified growth drivers across geographies, sectors and themes, and lower correlation with the dynamics that have driven US equity performance in recent years.
Waistell and Hovasse argue that the next phase of EM performance will not be driven by broad market beta. Dispersion is rising across countries, sectors and individual companies. In this environment, active management, conviction and disciplined stock selection become critical.
"The winners will not be the market. They will be specific companies and themes identified through genuine analytical depth and on-the-ground expertise," they added.
In their view, remaining materially underweight EMs is not a neutral position: "EMs are not just an opportunity. They are a risk if ignored. Investors who remain underweight are effectively making a strong, implicit bet that global growth will continue to be dominated by developed economies, that innovation will remain concentrated in a handful of US companies, and that valuation gaps will persist indefinitely. These are increasingly fragile assumptions."
Global capital remains significantly under allocated to EM relative to their weight in the global economy. As perceptions shift, even a modest reallocation could act as a powerful additional tailwind.
Our emerging market equity team believes the asset class is undergoing a profound transformation: from cyclical to structural, from peripheral to central in global growth, from a source of volatility to a source of diversification and long-term return. The fundamentals are improving, valuations are compelling and the macro environment is shifting in the asset class's favour.
"We are witnessing not just a cyclical rebound, but a structural transformation of the asset class, one that is reshaping its role in global portfolios," Waistell and Hovasse concluded. "The real question is no longer whether investors should allocate to EMs. It is whether they can afford not to."
1Sources: BoAML Research, Bloomberg, 12/01/2026.
2Source: NVIDIA, BofA Global Research estimates, October 2025.
3PEG ratio (price/earnings to growth ratio).
4Sources: MS Research, Bloomberg, 15/04/2026.
*Risk Scale from the KID (Key Information Document). Risk 1 does not mean a risk-free investment. This indicator may change over time. **Sustainable Finance Disclosure Regulation (SFDR) 2019/2088. The SFDR classification of the Funds may change over time.
MARKETING COMMUNICATION. Please refer to the KID/prospectus of the Fund before making any final investment decisions.
This document may not be reproduced, in whole or in part, without prior authorisation from the management company. It does not constitute a subscription offer, nor does it constitute investment advice. The information contained in this document may be partial information and may be modified without prior notice. The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights in French, English, German, Dutch, Spanish and Italian at the following link (paragraph 5 “Summary of investor rights”): https://www.carmignac.com/en/regulatory-information. The decision to invest in the promoted fund should take into account all its characteristics or objectives as described in its prospectus. Carmignac Portfolio Emergents refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged. Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. Access to the Funds may be subject to restrictions with regard to certain persons or countries. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a U.S. person, according to the definition of the US Regulation S and/or FATCA. The Funds present a risk of loss of capital. The risk, fees and ongoing charges are described in the KIDs (Key Information Document). The Funds' prospectuses, KIDs, NAV and annual reports are available at www.carmignac.com, or upon request to the Management Company. The KIDs must be made available to the subscriber prior to subscription.
For Belgium: This document is intended for professional clients only and has not been submitted to the FSMA. This communication is published by Carmignac Gestion S.A., a portfolio management company approved by the Autorité des Marchés Financiers (AMF) in France, and its Luxembourg subsidiary Carmignac Gestion Luxembourg, S.A., an investment fund management company approved by the Commission de Surveillance du Secteur Financier (CSSF). “Carmignac” is a registered trademark. “Investing in your Interest” is a slogan associated with the Carmignac trademark. The prospectus, KID, the net asset-values and the latest (semi-) annual management report may be obtained, free of charge, in French or in Dutch, from the management company (tel. +352 46 70 60 1) or by consulting its website or www.fundinfo.com. These materials may also be obtained from Caceis Belgium S.A., the financial service provider in Belgium, at the following address: avenue du port, 86c b320, B-1000 Brussels. In case of subscription to a fund subject to Article 19bis of the Belgian Income Tax Code (CIR92), the investor will have to pay, upon redemption of his or her shares, a withholding tax of 30% on the income (in the form of interest, or capital gains or losses) derived from the return on assets invested in debt claims. Distributions are subject to withholding tax of 30% without income distinction. Any complaint may be referred to complaints@carmignac.com or CARMIGNAC GESTION - Compliance and Internal Controls - 24 place Vendôme Paris France or on the website www.ombudsfin.be.
In Switzerland, the Funds’ prospectuses, KIDs and annual reports are available at www.carmignac.com/en-ch or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, succursale de Nyon / Suisse, Route de Signy 35, 1260 Nyon. The KID must be made available to the subscriber prior to subscription.
Carmignac Gestion, 24, place Vendôme - 75001 Paris. Portfolio management company authorised by the AMF - S.A. with a capital of €13,500,000 - Paris Civil Liability B 349 501 676.
Carmignac Gestion Luxembourg, City Link - 7, rue de la Chapelle - L-1325 Luxembourg. Subsidiary of Carmignac Gestion - Investment fund management company approved by the CSSF. S.A. with a capital of 23 000 000 € - R.C.S Luxembourg B 67 549.